4.4-(disubstituted)cyclohexan-1-ols-monomers and related...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 271/02 (2006.01) A61K 31/38 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) C07C 45/68 (2006.01) C07C 45/78 (2006.01) C07C 49/753 (2006.01) C07C 65/40 (2006.01) C07C 69/76 (2006.01) C07C 205/45 (2006.01) C07C 311/08 (2006.01) C07D 213/30 (2006.01) C07D 213/40 (2006.01) C07D 231/12 (2006.01) C07D 239/42 (2006.01) C07D 263/32 (2006.01) C07D 271/06 (2006.01) C07D 271/113 (2006.01) C07D 277/24 (2006.01) C07D 285/04 (2006.01) C07D 333/38 (2006.01) C07D 413/04

Patent

CA 2222561

The present invention relates to novel 4.4-(disubstituted)cyclohexan-1-ols monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhibiting the production of Tumor Necrosis Factor (TNF).

L'invention concerne des nouveaux monomères de 4,4-cyclohexan(disubstitué)-1-ols et des composés s'y rapportant, des compositions pharmaceutiques contenant ces composés et leur utilisation dans le traitement d'affections allergiques et inflammatoires et pour l'inhibition de la production du facteur de nécrose tumorale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

4.4-(disubstituted)cyclohexan-1-ols-monomers and related... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4.4-(disubstituted)cyclohexan-1-ols-monomers and related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4.4-(disubstituted)cyclohexan-1-ols-monomers and related... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1845082

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.